| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1 | 2017 | Using the Residual Dipolar Couplings Technique Combined with Chemical Unfolding to Probe for the Structural Stability of Human Gamma-D Crystallin Associated with Cataract, | S. S. Hsueh; S. S.-S. Wang ; T. H. Lin; J. W. Wu | | | | |
2 | 2016 | Using Nuclear Magnetic Resonance Spectroscopy to Examine the Structural Stability of Human GammaD Crystallin Associated with Cataract, | S. S. Hsueh; S. S.-S. Wang ; J. W. Wu; T. H. Lin | | | | |
3 | 2015 | Using Doxorubicin-loaded poly(L-glutamic acid)-b-polyglycine-g-lactobionolactone micelles as potential therapeutic agents for Hepatocellular carcinoma | S. C. How; C. C. Chang; J. S. Jan; S. S.-S. Wang | | | | |
4 | 2015 | Using Doxorubicin-encapsulated poly(L-glutamic acid)-b-polyglycine-g-lactobionolactone micelles as therapeutic agents for Hepatocellular carcinoma | S. C. How; C. C. Chang; J. S. Jan; S. S.-S. Wang | | | | |
5 | 2015 | Understanding the Structure Transition and Possible Amyloid-Fibril Formation Mechanism of Human £^D-Crystallin Associated with Cataract | J. W. Wu; C. K. Chang; H. S. Liu; S. S.-S. Wang | | | | |
6 | 2014 | Synthesis and Self-Assembly of Bioactive Saccharide-Conjugated Polypeptide Micelles for Acid-Triggered Drug Release | Y. D. Chen; Y. C. Huang; S. C. How; J. S. Jan; S. S.-S. Wang | | | | |
7 | 2014 | Synthesis and Self-assembly of Bioactive Saccharide-Conjugated Polypeptide Micelles for Acid-Triggered Drug Release | Y. D. Chen; Y. C. Huang; S. C. How; J. S. Jan; S. S.-S. Wang | | | | |
8 | 2015 | Synthesis and Characterization of Resveratrol-Containing Lotion by Double Emulsion Method | H. Y. Duan; C. Y. Kuo; M. Y. Chang; C. S.; S. J. Lin; C. A. Dai; S. S.-S. Wang ; W. Y. Chiu; J. T. Lai | | | | |
9 | 2015 | Synthesis and characterization of p(2-hydroxyethyl methacrylate-co-methacrylic acid) hydrogel, | G. Chen; S. S.-S. Wang ; M. J. Wang | | | | |
10 | 2014 | Synthesis and characterization of p(2-hydroxyethyl methacrylate-co-methacrylic acid) hydrogel | G. Chen; S. S.-S. Wang ; Meng-Jiy Wang | | | | |
11 | 2014 | Synthesis and Characterization of Functional Component-Containing Lotion by Double Emulsion Method | H. Y. Duan; C.-Y. Kuo; M.Y. Chang; C. Shen; S.-J. Lin; C. A. Dai; S. S.-S. Wang ; W. Y. Chiu; J. T. Lai | | | | |
12 | 2015 | Suppression of Amyloid Fibril Formation of Lysozyme by Erioglaucine, | Y. H. Chen; S. S.-S. Wang | | | | |
13 | 2014 | Suppression of Amyloid Fibril Formation of Lysozyme by Erioglaucine | Y. H. Chen S. S.-S. Wang | | | | |
14 | 2016 | Purification Of Lysozyme Using Brown Mx-5br Modified Poly-Acetonitrile Membrane, | J. C.-T. KUO; Y. K. CHANG; S. S.-S. Wang | | | | |
15 | 2015 | Protein Aggregation Diseases and Searching for Potential Inhibitory Molecules, | S. S.-S. Wang | | | | |
16 | 2013 | Probing the Structural stability of Human D-crystallin by NMR Spectroscopy | P. Y. Huang; J. W. Wu; T. H. Lin; S. S.-S. Wang | | | | |
17 | 2013 | Preparation of dye ligand affinity nanofibrous membrane and its application to lysozyme adsorption | S. S.-S. Wang ; S. M. Yang; A. Hsin; Y. K. Chang | | | | |
18 | 2016 | Preparation and Characterization of Graphene-Amyloid Fibrils Hybrid Nanomaterials, | M. C. Chung; S. S.-S. Wang | | | | |
19 | 2016 | Mono and dual responsive degradable micelles for intracellular anticancer drug delivery, | S. C. HOW; Y. F. CHEN; P. L. HSIEH; S. S.-S. Wang ; J. S. JAN | | | | |
20 | 2015 | Molecular Insights into the Structural Alteration and Possible Amyloid-Fibril Formation Pathway of Human £^D-Crystallin Proteins, | C. K. Chang; S. S.-S. Wang ; J. W. Wu | | | | |
21 | 2014 | Molecular Dynamics Simulations to Investigate the Structural Transition of Human £^D-Crystallin under Low pH | C. K. Chang; S. S.-S Wang ; J. W. Wu | | | | |
22 | 2017 | Investigating the Suppressing Effects of Brilliant Blue G on Amyloid Fibrillogenesis of Lysozyme, | W. T. Hsu; A. Hsin; J. W. Wu; S. S.-S. Wang | | | | |
23 | 2015 | Investigating the Influence of Quercetin on the UV-C Irradiation-Induced Aggregation of Human £^D-Crystallin Protein, | J. W. Wu; W. A. Chen; M. C. Chung; S. S.-S. Wang | | | | |
24 | 2013 | The Intracellular Drug Delivery of Bioactive Saccharide-Modified Polypeptide Micelles Loaded with Doxorubicin | S. C. How; C. C. Chang; J.-S. Jan; S. S.-S. Wang | | | | |
25 | 2017 | Instrumentation for sFLASH | Shin B.K.; Atwood S.; Belov K.; Belz J.; Chen P.; Field C.; Fukushima M.; Hast C.; Huang J.; Huey H.; Liu T.; Ivanov D.; Jobe K.; Jui C.; Nam J.; Naudet C.; Matthews J.; Potts M.; Reil K.; Saltzberg D.; Sokolsky P.; Thomas S.; Thomson G.B.; Wang S. ; sFLASH | Proceedings of Science | 0 | | |
26 | 2015 | The Inhibition Behavior of Erythrosine on Amyloid Fibril Formation of Lysozyme, | Y. L. Chen; M. Y. Chang; S. S.-S. Wang | | | | |
27 | 2017 | Inhibiting Amyloid Fibrillation by Magnetite Nanoparticles, | Chien-Yu Lin1; Ning-Hui Lu1; Zuzana Gazova; S. S.-S. Wang | | | | |
28 | 2016 | Exploring The Structural Stability Of Human £Fd-Crystallin By Single-Point Mutations, | C. H. LO; S. S.-S. Wang | | | | |
29 | 2017 | Exploring the Structural Stability of Human Gamma-D Crystallin Proteins Using the Residual Dipolar Couplings Technique Combined with Chemical Unfolding, | S. S. Hsueh; S. S.-S. Wang ; T. H. Lin; J. W. Wu | | | | |
30 | 2017 | Exploring the Inhibitory Activity of Brilliant Blue G Toward the Formation of Amyloid Fibrils Derived from Lysozyme, | W. T. Hsu; A. H.; J. W. Wu; S. S.-S. Wang | | | | |
31 | 2016 | Exploring The Formation Of Cataract Under Uv-C Irradiation And The Inhibiting Effect Of Quercetin To Form Cataract, | M. C. CHUNG; C. K. CHANG; S. S.-S. Wang ; J. W. WU | | | | |
32 | 2015 | Exploring the Effect of Quercetin on Human £^D Crystallin Proteins Associated with Cataract | M. C. Chung; W. A. Chen; S. S.-S. Wang ; J. W. Wu | | | | |
33 | 2013 | Exploring Carnosine¡¦s Mechanism of Action in Amyloid Fibril Inhibition | W. A. Chen; K. N. Liu; J. W. Wu; S. S.-S. Wang | | | | |
34 | 2016 | Exploit Amyloid-Based Materials as a new drug delivery system, | Y. H. Cheng; S. S.-S. Wang | | | | |
35 | 2017 | Exploit Amyloid-Based Materials as a new drug delivery system, | S. C. How; S. S.-S. Wang | | | | |
36 | 2014 | Examining the Unfolding Pathway of Human £^D-Crystallin under Acidic Conditions by Molecular Dynamics Simulations | C. K. Chang; S. S.-S Wang ; J. W. Wu | | | | |
37 | 2016 | Examining the Structural Stability of Human ƒ×D-Crystallin Protein Associated with Cataract, | J. W. Wu; S. S. Hsueh; T. H. Lin; S. S.-S. Wang | | | | |
38 | 2013 | Examining the Mechanism of Carnosine¡¦s Inhibitory Activity Toward Amyloid Fibrillogenesis and Induced Cytotoxicity of Lysozyme | W. A. Chen; K. N. Liu; J. W. Wu; S. S.-S. Wang | | | | |
39 | 2014 | Examining the Inhibitory Potency of Fast Green FCF Against Amyloid Fibrillogenesis of Lysozyme | S. M. Yang; A. Hsin; S. S.-S. Wang | | | | |
40 | 2014 | Examining the Inhibitory Effect of Methylene Blue on Amyloid Fibril Formation of Lysozyme | S. C. H. Lo S. S.-S. Wang | | | | |
41 | 2015 | Examining the Inhibitory Effect of Erioglaucine on Amyloid Fibril Formation of Lysozyme | Y. H. Chen S. S.-S. Wang | | | | |
42 | 2016 | EXAMINING THE INHIBITORY EFFECT OF COOMASSIE BRILLIANT BLUE R-250 ON AMYLOID FIBRIL FORMATION OF LYSOZYME, | C. P. TSENG; S S.-S. WANG | | | | |
43 | 2013 | Examining the Influence of Glycation on Human £^D-Crystallin Associated with Cataract | C. T. Li; J. W. Wu; S. S.-S. Wang | | | | |
44 | 2015 | Examining the Effects of Brilliant Blue G on Aggregation Behavior of Lysozyme, | S. M. Yang; A. Hsin; S. S.-S. Wang | | | | |
45 | 2014 | Examining the Effects of Brilliant Blue G on Aggregation Behavior of Lysozyme | S. M. Yang; A. Hsin; S. S.-S. Wang | | | | |
46 | 2015 | Examining the Effect of Coomassie Brilliant Blue R-250 on the Formation of Ordered Protein Aggregates | C. P. Tseng; S. S.-S. Wang | | | | |
47 | 2014 | Examining the Aggregation Behavior of the Wild Type and Mutant Human £^D-Crystallin Proteins under Different pH Conditions | W. A. Chen; W. S. Wen; J. W. Wu; S. S.-S. Wang | | | | |
48 | 2016 | Examination Of The Effects Of Methylene Blue On Amyloid Fibrillogenesis Of Human Insulin, | C. C. LIANG; S. S.-S. Wang | | | | |
49 | 2016 | Examination of the Brilliant blue G Inhibitory potency toward the fibrillogenesis of human insulin, | J. C.-L. Hsu; S. S.-S. Wang | | | | |
50 | 2016 | Effects of Glycation on Human £^D-Crystallin Proteins by Different Glycation-Inducing Agents, | S. C. How; C. T. Li; C. H. Lo; M. C. Chun; C. K. Chang; W. A. Chen; J. W. Wu; S. S.-S. Wang | | | | |
51 | 2016 | Effects of ceria nanoparticles on the structure and activity of lysozyme, | Y. H. Cheng; C. M. Lai; K. S. Lin; S. S.-S. Wang | | | | |
52 | 2014 | Effects of Brilliant Blue G on Amyloid Fibril Formation of Lysozyme | A. Hsin; S. M. Yang; S. S.-S. Wang | | | | |
53 | 2013 | Effect of Plasma Pretreatment on Amyloid Fibril Formation of Lysozyme | C. K. Chang; W. A. Chen; C. Y. Sie; S. C. Lin; C. C; Hsu; S. S.-S. Wang | | | | |
54 | 2014 | Effect of Erythrosine on Amyloid fibril of Lysozyme | Y. L. Chen; S. C. H. Lo; S. S.-S. Wang | | | | |
55 | 2016 | Dual Redox- And Ph-Responsive Pll-G-Lipo-G-Lac/Paa Pic Micelles For Intracellular Anticancer Drug Delivery, | S. C. HOW; Y. F. CHEN; P. L. HSIEH; S. S.-S. Wang ; J. S. JAN | | | | |
56 | 2015 | Dual Redox- and pH-responsive Complex Micelles Assembled from Saccharide/Lipoic Acid-Modified Poly(L-lysine) and Poly(acrylic acid) for Cell-Targeted Drug Delivery | S. C. How; P. L. Hsieh; J. S. Jan; S. S.-S. Wang | | | | |
57 | 2016 | Development of Silicone-Containing Soft Hydrogel in the Application of Artificial Cornea, | H. Y. Duan; S. S.-S. Wang ; Chi-An Dai | | | | |
58 | 2017 | Developing an Amyloid Fibril-Based Hybrid Biomaterials for Drug Delivery, | H. M. Hsiao; S. Y. Shen; Y. H. Cheng; S. S.-S. Wang | | | | |
59 | 2015 | Can Methylene Blue Serve as a Promising Inhibitory Molecule Against Amyloid Fibril Formation? | S. C. H. Lo; S. S.-S. Wang | | | | |
60 | 2014 | Bioactive Saccharide-Conjugated Polypeptide Micelles for Acid-Triggered Doxorubicin Delivery | S. C. How; Y. D. Chen; J.-S. Jan; Steven S.-S. Wang | | | | |
61 | 2015 | Adsorption of Lysozyme by Reactive Green 19 Immobilized Affinity Membranes, | C. W. Tai; Y. K. Chang; S. S.-S. Wang | | | | |
62 | 2013 | Adsorption characteristics of lysozyme by dye ligand affinity nanofibrous membrane | S. S-S. Wang ; A. Hsin; S. M. Yang; Y. K. Chang | | | | |